MANUFACTURERS LIFE INSURANCE COMPANY, THE - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$80,172
-48.9%
30,027
-17.4%
0.00%
Q4 2021$157,000
-19.1%
36,350
-4.4%
0.00%
Q3 2021$194,000
-22.1%
38,032
-3.2%
0.00%
Q2 2021$249,000
-13.8%
39,281
+5.0%
0.00%
Q1 2021$289,000
+46.7%
37,421
+24.4%
0.00%
Q4 2020$197,000
+7.1%
30,075
+8.9%
0.00%
Q3 2020$184,000
-18.9%
27,6260.0%0.00%
Q2 2020$227,000
-1.3%
27,626
-7.8%
0.00%
Q1 2020$230,000
-3.0%
29,977
+5.0%
0.00%
Q4 2019$237,000
+5.8%
28,556
-1.9%
0.00%
Q3 2019$224,000
-31.5%
29,1140.0%0.00%
Q2 2019$327,000
+1.6%
29,114
-2.8%
0.00%
Q1 2019$322,000
-22.6%
29,957
+8.9%
0.00%
-100.0%
Q4 2018$416,000
-23.4%
27,517
-6.2%
0.00%0.0%
Q3 2018$543,000
-18.5%
29,336
+0.9%
0.00%0.0%
Q2 2018$666,000
+6.7%
29,085
+32.7%
0.00%0.0%
Q1 2018$624,000
+30.8%
21,921
-3.1%
0.00%0.0%
Q4 2017$477,000
+14.1%
22,626
-1.7%
0.00%
Q3 2017$418,000
+14.5%
23,007
-2.2%
0.00%
Q2 2017$365,000
+23.3%
23,529
+36.9%
0.00%
Q1 2017$296,000
+75.1%
17,187
+11.5%
0.00%
Q4 2016$169,000
-30.2%
15,419
-0.2%
0.00%
Q3 2016$242,000
+50.3%
15,444
-1.9%
0.00%
Q2 2016$161,000
+117.6%
15,746
+171.5%
0.00%
Q1 2016$74,0005,8000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders